Human CD8 T cells were enriched from peripheral blood mononuclear cells (PBMCs) and, after sorting, were stained with CD4-FITC (Clone: OKT4) and CD8-APC (Clone: SK1). Analysis was performed by gating on live cells (Live+). Flow cytometric results indicated that the purity of the sorted Human CD8 T cells was 91%.
Product Details
Product Details
Product Specification
| Format |
1 mL Human CD8 T Cell Biotin-Antibody Cocktail 1 mL Streptavidin Beads |
| Capacity | Suitable for a total cell count of 1×10⁹, and can perform up to 100 sorting runs. |
| Principle of Separation | In this negative selection process, non-CD8 T cells are labeled with biotin-conjugated antibodies, and the cells are then incubated with streptavidin‑nanomagnetic beads. As a result, the non‑target cells are marked by the antibody‑bead complex, while the target CD8 T cells remain unlabeled. Subsequently, the cell suspension is loaded onto a separation column; under the influence of a magnetic field, the magnetically labeled non‑target cells are retained within the column, whereas the unlabeled CD8 T cells elute into a collection tube under gravity. The resulting supernatant constitutes the CD8 T cell‑enriched fraction after removal of the non‑target cells. |
| Reactivity | Human |
| Magnetic Bead Size | 20 nm |
| Separation Method | Column-Based |
| Selection Strategy | Negative Selection |
| Stability & Storage | Store protected from light at 2–8°C; do not freeze. |
Background
Human CD8 T lymphocytes are the core effector cells of adaptive cellular immunity in the human body, playing a crucial role in host anti-infection immunity, tumor immune surveillance, and immune homeostasis regulation. Due to their precise antigen specificity, potent cytotoxic function, and immunological memory characteristics, human CD8 T cells are central research subjects in fields such as immunological mechanism studies, anti-infection vaccine development, tumor immunotherapy (e.g., CAR-T cell therapy), and immune function assessment, possessing significant scientific research and clinical application value. This kit employs a column-based negative selection approach: non-CD8 T cells are labeled with biotin-conjugated antibodies, and magnetic bead sorting is used to remove non-target cells, thereby enriching highly pure, high‑activity CD8 T cells. This method avoids the potential impact of direct labeling of CD8 T cells on cellular function and is suitable for subsequent experimental studies, including cell culture and functional assays.
Protocol
|
TakingL Separation Columnas an example
| |||||||||||||||||||||||||||||||||||||
Picture
Picture
Validation Data
